ELV — Elevance Health Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual cashflow statement for Elevance Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	4,807	4,572	6,095	6,019	5,991
Depreciation
Deferred Taxes
Non-Cash Items	346	481	349	271	742
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-306	5,021	292	510	185
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Gains / Losses on Investment Securities
Change in Reinsurance Receivable
Change in Unearned Premiums
Cash from Operating Activities	6,061	10,688	8,364	8,399	8,061
Capital Expenditures	-1,077	-1,021	-1,087	-1,152	-1,296
Purchase of Fixed Assets
Other Investing Cash Flow Items	-1,715	-6,303	-8,551	-3,408	-4,276
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-2,792	-7,324	-9,638	-4,560	-5,572
Financing Cash Flow Items	-338	1,209	505	250	-169
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-2,266	-2,567	423	-1,318	-3,349
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,003	804	-861	2,507	-861